MONOPAR THERAPEUTICS INC MNPR
COM · Common Stock · CUSIP 61023L108
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersWilmette, IL
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.68.
Trends to Q1 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 11 |
| Q4 2022 | 11 |
| Q1 2023 | 12 |
| Q2 2023 | 9 |
| Q3 2023 | 15 |
| Q4 2023 | 15 |
| Q1 2024 | 17 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 5 | 5 |
| Q1 2023 | 5 | 3 |
| Q2 2023 | 4 | 6 |
| Q3 2023 | 7 | 6 |
| Q4 2023 | 8 | 6 |
| Q1 2024 | 9 | 5 |
Biggest buyers
| MILLENNIUM MANAGEMENT LLC | Added | +163.0k |
| HRT FINANCIAL LP | New | +32.1k |
| FMR LLC | New | +5.5k |
| Tower Research Capital LLC (TRC) | Added | +4.2k |
| NewEdge Advisors, LLC | New | +3.0k |
| WELLS FARGO & COMPANY/MN | Added | +1.5k |
| MORGAN STANLEY | Added | +800 |
| BANK OF AMERICA CORP /DE/ | New | +500 |
| ROYAL BANK OF CANADA | New | +100 |
Biggest sellers
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -48.1k |
| TWO SIGMA INVESTMENTS, LP | Sold out | -14.3k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -11.0k |
| UBS Group AG | Reduced | -9.3k |
| Virtu Financial LLC | Reduced | -3.3k |
Insider purchases and sales in Q1 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q2 2022 | 0 | — | 0 | — | — |
| Q3 2022 | 0 | — | 0 | — | — |
| Q4 2022 | 1 | $49.7k | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 0 | — | 0 | — | — |
| Q3 2023 | 0 | — | 0 | — | — |
| Q4 2023 | 0 | — | 0 | — | — |
| Q1 2024 | 0 | — | 0 | — | — |
None reported in Q1 2024.
Holders, Q1 2024
| Manager | Shares | Change |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 192.4k $131.0k | Added +163.0k |
| VANGUARD GROUP INC 0.00% of their portfolio | 45.2k $30.8k | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 41.2k $28.1k | Unchanged |
| HRT FINANCIAL LP 0.00% of their portfolio | 32.1k $21.0k | New |
| GERBER, LLC 0.02% of their portfolio | 28.0k $19.1k | Unchanged |
| Virtu Financial LLC 0.00% of their portfolio | 23.8k $16.0k | Reduced -3.3k |
| Rappaport Reiches Capital Management, LLC 0.00% of their portfolio | 10.7k $7.3k | Unchanged |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 7.9k $5.3k | Added +4.2k |
| FMR LLC 0.00% of their portfolio | 5.5k $3.7k | New |
| NewEdge Advisors, LLC 0.00% of their portfolio | 3.0k $2.0k | New |
| UBS Group AG 0.00% of their portfolio | 2.6k $1.7k | Reduced -9.3k |
| MORGAN STANLEY 0.00% of their portfolio | 2.4k $1.6k | Added +800 |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 1.5k $1.0k | Added +1.5k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 500 $340 | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 100 $0 | New |
| Federation des caisses Desjardins du Quebec 0.00% of their portfolio | 80 $54 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |